Tonix Pharmaceuticals Holding (TNXP) Intangibles (2015 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted Intangibles of $120000.0 for Q2 2026, little changed on a QoQ basis from $120000.0 in Q1 2026, and little changed year-over-year from $120000.0 in Q2 2025.
Analysis
Tonix Pharmaceuticals Holding (TNXP) Intangibles (2015 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding has reported Intangibles for 12 years, with the latest figure at $120000.0 in Q2 2026.
- On a quarterly basis, Intangibles changed 0.0% year-over-year to $120000.0 in Q2 2026; TTM through Jun 2026 was $120000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $120000.0, changed 0.0% from the prior year.
- Intangibles was $120000.0 for Q2 2026 at Tonix Pharmaceuticals Holding, roughly flat from $120000.0 in the prior quarter.
- The five-year high for Intangibles was $10.2 million in Q2 2023, with the low at $120000.0 in Q4 2022.
- Average Intangibles over 5 years is $2.9 million, with a median of $120000.0 recorded in 2022.
- The sharpest annual moves came in 2023 and 2024: Intangibles surged 8019.17% in 2023, then sank 98.83% in 2024.
- Over 5 years, Intangibles stood at $120000.0 in 2022, then soared by 8019.17% to $9.7 million in 2023, then plunged by 98.77% to $120000.0 in 2024, then changed by 0.0% to $120000.0 in 2025, then changed by 0.0% to $120000.0 in 2026.
- The last three Intangibles figures came in at $120000.0 (Q2 2026), $120000.0 (Q1 2026), and $120000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 47.05 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 30.64 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | 63.28 Mn |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | 60.96 Mn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 103.20 Mn |
| 10 | Tonix Pharmaceuticals Holding | 220.65 Mn | 220.65 Mn | 12.84 Mn | 120,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 120,000.00 |
| Mar 31, 2026 | 120,000.00 |
| Dec 31, 2025 | 120,000.00 |
| Sep 30, 2025 | 120,000.00 |
| Jun 30, 2025 | 120,000.00 |
| Mar 31, 2025 | 120,000.00 |
| Dec 31, 2024 | 120,000.00 |
| Sep 30, 2024 | 120,000.00 |
| Jun 30, 2024 | 120,000.00 |
| Mar 31, 2024 | 9.51 Mn |
| Dec 31, 2023 | 9.74 Mn |
| Sep 30, 2023 | 9.98 Mn |
| Jun 30, 2023 | 10.22 Mn |
| Dec 31, 2022 | 120,000.00 |
| Dec 31, 2021 | 120,000.00 |
| Sep 30, 2021 | 120,000.00 |
| Jun 30, 2021 | 120,000.00 |
| Mar 31, 2021 | 120,000.00 |
| Dec 31, 2020 | 120,000.00 |
| Sep 30, 2020 | 120,000.00 |